Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCML Microcircuits Regulatory News (CML)

Share Price Information for CML Microcircuits (CML)

Share Price is delayed by 15 minutes
Get Live Data
287.50    -17.50 (-5.74%)
Bid:
280.00
Ask:
295.00
Spread: 15.00 (5.357%)
Market Cap: £47.89m
CML Live PriceLast checked at - London Stock Exchange

Intraday CML Microcircuits Share Chart

Trading Update

27 Mar 2025 12:42

RNS Number : 5467C
CML Microsystems PLC
27 March 2025
 

27 March 2025

CML Microsystems Plc

("CML", the "Company" or the "Group") 

Trading Update

CML today announces a trading update for the year ended 31 March 2025.

The market environment through the second half of the financial year continued to be challenging, with the softness from industrial markets persisting, particularly affecting established customers for the Groups anchor products. Nevertheless, good progress has been made with expanding the opportunity pipeline for the enlarged product portfolio and there are encouraging signs that we may be at, or very near, the bottom of the inventory correction that has featured strongly across recent reporting periods.

Operationally, the Group is pleased to report that the US Silicon Valley team has just completed its relocation to a new, smaller facility. This follows a protracted period whereby the Group was incurring additional expense while awaiting the issue of the relevant building permits to allow planned refurbishment to take place and the move to be completed.

From a trading perspective, revenue for the full year to 31 March 2025 will comprise a product mix quite different from that originally envisaged, with SµRF products making a higher contribution than expected and the core product range somewhat less. Total revenue is now expected to be broadly flat against the prior year. The combined effect of product mix and temporarily elevated US running costs resulted in a second half trading period that was only marginally profitable, which is below market expectations. EBITDA is expected to exceed £5m, with a net cash balance of just over £9m being ahead of the planned level when ad hoc share-buybacks of circa £0.9m are taken into account. The FY25 EBITDA estimate excludes an exceptional goodwill write-off associated with the restructuring of the UK R&D team, as communicated at the time of the interim results in November 2024.

In recent years, the Group has significantly expanded its semiconductor product portfolio, both organically and through acquisition. These innovative solutions have shown early positive signs of market acceptance, evidenced by strong growth in the opportunity pipeline. We are confident that they will drive future growth, and through the ongoing penetration of adjacent markets, help mitigate the impact of demand fluctuations across some of the Group's traditional end-market areas. Our global teams remain focused on accelerating the launch and promotion of these new products, and we are actively investing in R&D to ensure we remain well-positioned moving forward.

While the short-term outlook remains subdued, our strategic focus on innovation and product diversification will pave the way for recovery and growth in the coming periods.

The Group will release its preliminary full year results on Tuesday 24 June 2025.

 

CML Microsystems Plc

Chris Gurry, Group Managing DirectorNigel Clark, Non-Executive Chairman

 

Tel: +44(0)1621 875 500

Shore Capital

Toby Gibbs

James Thomas

Lucy Bowden

Fiona Conroy (Corporate Broking)

 

 Tel: +44(0)20 7408 4090 

Alma Strategic Communications

Josh Royston

Andy Bryant

Robyn Fisher

Emma Thompson

 Tel: +44 (0)20 3405 0212

 

 

About CML Microsystems Plc

CML develops mixed-signal, RF and microwave semiconductors for global communications markets. The Group utilises a combination of outsourced manufacturing and in-house testing with trading operations in the UK, Asia and USA. CML targets sub-segments within Communication markets with strong growth profiles and high barriers to entry. It has secured a diverse, blue chip customer base, including some of the world's leading commercial and industrial product manufacturers.

Growth in its end markets is being driven by factors such as the appetite for data to be transmitted faster and more securely, the upgrading of telecoms infrastructure around the world and the growing prevalence of private commercial wireless networks for voice and/or data communications linked to the industrial internet of things (IIoT).

The Group is cash-generative, has no debt and is dividend paying.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFSFVFIDFIE
Date   Source Headline
28th Apr 202612:00 pmRNSNotice of Results
8th Apr 20267:00 amRNSTransfer of Treasury Shares
1st Apr 20267:00 amRNSTrading Statement
27th Mar 202610:38 amRNSBlock Listing Interim Return
23rd Mar 20261:47 pmRNSDirector/PDMR Dealing
11th Mar 20267:00 amRNSExercise of Options, PDMR & Total Voting Rights
18th Nov 20257:00 amRNSHalf Year Results
6th Nov 20257:00 amRNSExercise of Options and Total Voting Rights
24th Oct 202510:49 amRNSExercise of Options and Total Voting Rights
22nd Oct 20257:00 amRNSNotice of Results
16th Oct 202512:36 pmRNSHolding(s) in Company
8th Oct 20257:00 amRNSDirector/PDMR Dealing
7th Oct 202512:28 pmRNSIssue of shares
2nd Oct 20257:00 amRNSTransfer of Treasury Shares & Total Voting Rights
30th Sep 20251:35 pmRNSHolding(s) in Company
29th Sep 20257:00 amRNSBlock listing Interim Return
12th Aug 20251:51 pmRNSDirector/PDMR Dealing
5th Aug 202512:33 pmRNSResult of AGM
5th Aug 20257:00 amRNSAGM Statement
17th Jul 20254:22 pmRNSExercise of Options and Total Voting Rights
14th Jul 20257:00 amRNSSale of Excess Land at Group Headquarters
11th Jul 20252:04 pmRNSPosting of Annual Report and Notice of AGM
10th Jul 20257:00 amRNSSignificant Long-Term GNSS Contract
24th Jun 20257:00 amRNSFull Year Results
22nd May 20251:32 pmRNSExercise of Options and Total Voting Rights
31st Mar 20259:36 amRNSDirector/PDMR Shareholding
27th Mar 202512:42 pmRNSTrading Update
27th Mar 20257:00 amRNSBLOCK LISTING INTERIM RETURN
4th Mar 20257:00 amRNSExercise of Options and Total Voting Rights
3rd Mar 202512:49 pmRNSDirector/PDMR Dealing
28th Feb 20259:10 amRNSTransaction in Own Shares and Total Voting Rights
10th Dec 20243:52 pmRNSTransaction in Own Shares and Total Voting Rights
5th Dec 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Dec 20249:15 amRNSTransaction in Own Shares and Total Voting Rights
2nd Dec 20243:04 pmRNSDirector/PDMR Shareholding
21st Nov 20247:00 amRNSTransaction in Own Shares & Total Voting Rights
19th Nov 20243:16 pmRNSTransaction in Own Shares & Total Voting Rights
19th Nov 20247:00 amRNSHalf Year Results
13th Nov 20247:00 amRNSChange of Auditor
4th Nov 20249:01 amRNSHolding(s) in Company
28th Oct 20247:00 amRNSNotice of Results
2nd Oct 202410:30 amRNSTransfer of Treasury Shares
27th Sep 20247:00 amRNSBlock listing Interim Return
25th Sep 202411:04 amRNSDirector/PDMR Shareholding
13th Aug 202411:08 amRNSAGM Statement
12th Aug 20247:00 amRNSExercise of Options and Total Voting Rights
16th Jul 20249:55 amRNSPosting of Annual Report & Notice of AGM
4th Jul 20243:25 pmRNSHolding(s) in Company
4th Jul 20241:38 pmRNSHolding(s) in Company
4th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.